moxonidine has been researched along with pefloxacin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Hennig, S; Karlsson, MO | 1 |
Karlsson, MO; Svensson, EM | 1 |
Bergstrand, M; Dosne, AG; Harling, K; Karlsson, MO | 1 |
7 other study(ies) available for moxonidine and pefloxacin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Concordance between criteria for covariate model building.
Topics: Docetaxel; Humans; Imidazoles; Leukocyte Count; Models, Biological; Neutrophils; Pefloxacin; Pharmacokinetics; Prazosin; Stochastic Processes; Taxoids | 2014 |
Use of a linearization approximation facilitating stochastic model building.
Topics: Ethambutol; Humans; Imidazoles; Models, Biological; Nonlinear Dynamics; Pefloxacin; Pharmacokinetics; Software; Stochastic Processes | 2014 |
Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling.
Topics: Administration, Oral; Algorithms; Computer Simulation; Confidence Intervals; Humans; Imidazoles; Injections, Intravenous; Models, Biological; Models, Statistical; Nonlinear Dynamics; Pefloxacin; Phenobarbital; Software; Uncertainty | 2016 |